iTeos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITOS and other ETFs, options, and stocks.About ITOS
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984.
CEOMichel Detheux
CEOMichel Detheux
Employees173
Employees173
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2012
Founded2012
Employees173
Employees173
ITOS Key Statistics
Market cap383.12M
Market cap383.12M
Price-Earnings ratio-3.10
Price-Earnings ratio-3.10
Dividend yield—
Dividend yield—
Average volume937.79K
Average volume937.79K
High today$10.12
High today$10.12
Low today$9.99
Low today$9.99
Open price$10.02
Open price$10.02
Volume637.47K
Volume637.47K
52 Week high$18.13
52 Week high$18.13
52 Week low$4.80
52 Week low$4.80
Analyst ratings
83%
of 6 ratingsBuy
16.7%
Hold
83.3%
Sell
0%
People also own
Based on the portfolios of people who own ITOS. This list is generated using Robinhood data, and it’s not a recommendation.